Global ?-Aminobutyric Acid Receptor Agonists Supply, Demand and Key Producers, 2026-2032
The global ?-Aminobutyric Acid Receptor Agonists market size is expected to reach $ 4465 million by 2032, rising at a market growth of 5.6% CAGR during the forecast period (2026-2032).
?-Aminobutyric Acid Receptor Agonists are pharmaceutical agents that produce therapeutic effects primarily by activating GABA receptors or by generating clinically relevant GABA-B receptor-related agonist activity. Commercial products mainly include baclofen oral tablets, oral suspensions, granules, and intrathecal injections, immediate-release and extended-release sodium oxybate formulations, mixed oxybate salt oral solutions, and a limited number of regionally approved phenibut medicines. By enhancing inhibitory neurotransmission in the central nervous system, these products reduce neuronal excitability and are mainly used for central spasticity associated with multiple sclerosis, spinal cord injury, and other neurological disorders, as well as for narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and selected regional neuropsychiatric indications. Key upstream inputs include baclofen, sodium oxybate, mixed mineral oxybate salts, phenibut, pharmaceutical-grade excipients, controlled-release polymers, flavoring agents, water for injection, sterile filtration materials, glass containers, and specialized pharmaceutical packaging. Major downstream customers include hospitals, neurology and neurosurgery departments, rehabilitation centers, sleep medicine centers, psychiatric institutions, specialty pharmacies, pharmaceutical distributors, and retail pharmacies. The estimated industry gross margin generally ranges from approximately 70% to 82%, with branded oxybate products and differentiated specialty formulations positioned toward the upper end of the range and conventional baclofen generics and regional prescription products positioned toward the lower end.
The global ?-Aminobutyric Acid Receptor Agonists market has a two-tier structure characterized by concentrated high-value specialty medicines and fragmented mature generic products. Oxybate medicines are primarily used for narcolepsy and idiopathic hypersomnia and account for most industry revenue because of their relatively high annual treatment value, specialized prescribing requirements, and controlled distribution systems. Baclofen products are widely used for central spasticity, while conventional oral formulations have entered a mature generic stage with numerous regional suppliers. Competition in the conventional segment mainly centers on supply reliability, registration coverage, hospital access, procurement pricing, and manufacturing cost control. Intrathecal baclofen and differentiated oral formulations remain more concentrated because of their higher requirements for sterile production, dose control, specialist administration, and long-term patient management.
From a product development perspective, oxybate medicines are evolving from traditional high-sodium and multiple-dose nightly regimens toward low-sodium formulations, extended-release delivery, and reduced dosing frequency. Product differentiation is increasingly focused on dosing convenience, sleep maintenance, next-day function, sodium burden, safety management, and patient adherence rather than on efficacy alone. Development in the baclofen segment is concentrated in high-concentration oral suspensions, granules, swallow-friendly liquid formulations, and multi-strength sterile injections designed for intrathecal infusion. These formulation improvements address the needs of pediatric patients, patients with swallowing difficulties, individuals requiring precise dose titration, and patients with severe treatment-resistant spasticity. Overall, technological progress is driven more by formulation optimization, administration convenience, and specialist treatment integration than by replacement of the underlying pharmacological mechanism.
Market growth is supported by improving diagnosis of narcolepsy, idiopathic hypersomnia, and severe neurological spasticity, as well as by the expansion of sleep medicine, neurology, rehabilitation, and specialist pharmacy networks. Narcolepsy and idiopathic hypersomnia remain underdiagnosed or are often diagnosed after prolonged delays, leaving additional treatment demand to be released as physician awareness, referral pathways, and patient education improve. Severe spasticity also creates sustained demand for individualized and long-term treatment, supporting continued use of intrathecal baclofen and differentiated oral formulations. Broader reimbursement coverage, improved commercial insurance access, and stronger specialist treatment infrastructure may further increase patient access to high-value products. In emerging markets, demand growth is expected to rely more heavily on generic baclofen availability, hospital coverage, and improvements in neurological care capacity.
The industry nevertheless faces significant regulatory, pricing, and substitution risks. Oxybate medicines are controlled central nervous system products and require strict prescribing, risk management, specialist distribution, and patient monitoring, which limits rapid expansion through conventional channels. The entry of authorized and conventional generics is expected to improve treatment access but will place downward pressure on the pricing and market share of established branded products. Conventional baclofen formulations face product commoditization, centralized procurement, and low-price competition, while intrathecal therapy remains constrained by procedure complexity and the availability of trained treatment centers. In the longer term, orexin receptor agonists, other wake-promoting medicines, and new treatment approaches for spasticity may divert part of existing demand. Competitive advantage will therefore increasingly depend on differentiated formulations, clinical evidence, reimbursement access, specialist distribution, supply reliability, and patient-management capabilities.
This report studies the global ?-Aminobutyric Acid Receptor Agonists demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for ?-Aminobutyric Acid Receptor Agonists, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of ?-Aminobutyric Acid Receptor Agonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global ?-Aminobutyric Acid Receptor Agonists total market, 2021-2032, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: ?-Aminobutyric Acid Receptor Agonists total market, key domestic companies, and share, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists revenue by player, revenue and market share 2021-2026, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by Type, CAGR, 2021-2032, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global ?-Aminobutyric Acid Receptor Agonists market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jazz Pharmaceuticals, Alkermes, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Piramal Pharma, Azurity Pharmaceuticals, Sagent Pharmaceuticals, Novartis, Daiichi Sankyo, Fuan Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world ?-Aminobutyric Acid Receptor Agonists market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global ?-Aminobutyric Acid Receptor Agonists Market, By Region:
1. How big is the global ?-Aminobutyric Acid Receptor Agonists market?
2. What is the demand of the global ?-Aminobutyric Acid Receptor Agonists market?
3. What is the year over year growth of the global ?-Aminobutyric Acid Receptor Agonists market?
4. What is the total value of the global ?-Aminobutyric Acid Receptor Agonists market?
5. Who are the Major Players in the global ?-Aminobutyric Acid Receptor Agonists market?
6. What are the growth factors driving the market demand?
?-Aminobutyric Acid Receptor Agonists are pharmaceutical agents that produce therapeutic effects primarily by activating GABA receptors or by generating clinically relevant GABA-B receptor-related agonist activity. Commercial products mainly include baclofen oral tablets, oral suspensions, granules, and intrathecal injections, immediate-release and extended-release sodium oxybate formulations, mixed oxybate salt oral solutions, and a limited number of regionally approved phenibut medicines. By enhancing inhibitory neurotransmission in the central nervous system, these products reduce neuronal excitability and are mainly used for central spasticity associated with multiple sclerosis, spinal cord injury, and other neurological disorders, as well as for narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and selected regional neuropsychiatric indications. Key upstream inputs include baclofen, sodium oxybate, mixed mineral oxybate salts, phenibut, pharmaceutical-grade excipients, controlled-release polymers, flavoring agents, water for injection, sterile filtration materials, glass containers, and specialized pharmaceutical packaging. Major downstream customers include hospitals, neurology and neurosurgery departments, rehabilitation centers, sleep medicine centers, psychiatric institutions, specialty pharmacies, pharmaceutical distributors, and retail pharmacies. The estimated industry gross margin generally ranges from approximately 70% to 82%, with branded oxybate products and differentiated specialty formulations positioned toward the upper end of the range and conventional baclofen generics and regional prescription products positioned toward the lower end.
The global ?-Aminobutyric Acid Receptor Agonists market has a two-tier structure characterized by concentrated high-value specialty medicines and fragmented mature generic products. Oxybate medicines are primarily used for narcolepsy and idiopathic hypersomnia and account for most industry revenue because of their relatively high annual treatment value, specialized prescribing requirements, and controlled distribution systems. Baclofen products are widely used for central spasticity, while conventional oral formulations have entered a mature generic stage with numerous regional suppliers. Competition in the conventional segment mainly centers on supply reliability, registration coverage, hospital access, procurement pricing, and manufacturing cost control. Intrathecal baclofen and differentiated oral formulations remain more concentrated because of their higher requirements for sterile production, dose control, specialist administration, and long-term patient management.
From a product development perspective, oxybate medicines are evolving from traditional high-sodium and multiple-dose nightly regimens toward low-sodium formulations, extended-release delivery, and reduced dosing frequency. Product differentiation is increasingly focused on dosing convenience, sleep maintenance, next-day function, sodium burden, safety management, and patient adherence rather than on efficacy alone. Development in the baclofen segment is concentrated in high-concentration oral suspensions, granules, swallow-friendly liquid formulations, and multi-strength sterile injections designed for intrathecal infusion. These formulation improvements address the needs of pediatric patients, patients with swallowing difficulties, individuals requiring precise dose titration, and patients with severe treatment-resistant spasticity. Overall, technological progress is driven more by formulation optimization, administration convenience, and specialist treatment integration than by replacement of the underlying pharmacological mechanism.
Market growth is supported by improving diagnosis of narcolepsy, idiopathic hypersomnia, and severe neurological spasticity, as well as by the expansion of sleep medicine, neurology, rehabilitation, and specialist pharmacy networks. Narcolepsy and idiopathic hypersomnia remain underdiagnosed or are often diagnosed after prolonged delays, leaving additional treatment demand to be released as physician awareness, referral pathways, and patient education improve. Severe spasticity also creates sustained demand for individualized and long-term treatment, supporting continued use of intrathecal baclofen and differentiated oral formulations. Broader reimbursement coverage, improved commercial insurance access, and stronger specialist treatment infrastructure may further increase patient access to high-value products. In emerging markets, demand growth is expected to rely more heavily on generic baclofen availability, hospital coverage, and improvements in neurological care capacity.
The industry nevertheless faces significant regulatory, pricing, and substitution risks. Oxybate medicines are controlled central nervous system products and require strict prescribing, risk management, specialist distribution, and patient monitoring, which limits rapid expansion through conventional channels. The entry of authorized and conventional generics is expected to improve treatment access but will place downward pressure on the pricing and market share of established branded products. Conventional baclofen formulations face product commoditization, centralized procurement, and low-price competition, while intrathecal therapy remains constrained by procedure complexity and the availability of trained treatment centers. In the longer term, orexin receptor agonists, other wake-promoting medicines, and new treatment approaches for spasticity may divert part of existing demand. Competitive advantage will therefore increasingly depend on differentiated formulations, clinical evidence, reimbursement access, specialist distribution, supply reliability, and patient-management capabilities.
This report studies the global ?-Aminobutyric Acid Receptor Agonists demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for ?-Aminobutyric Acid Receptor Agonists, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of ?-Aminobutyric Acid Receptor Agonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global ?-Aminobutyric Acid Receptor Agonists total market, 2021-2032, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: ?-Aminobutyric Acid Receptor Agonists total market, key domestic companies, and share, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists revenue by player, revenue and market share 2021-2026, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by Type, CAGR, 2021-2032, (USD Million)
Global ?-Aminobutyric Acid Receptor Agonists total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global ?-Aminobutyric Acid Receptor Agonists market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jazz Pharmaceuticals, Alkermes, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Piramal Pharma, Azurity Pharmaceuticals, Sagent Pharmaceuticals, Novartis, Daiichi Sankyo, Fuan Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world ?-Aminobutyric Acid Receptor Agonists market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global ?-Aminobutyric Acid Receptor Agonists Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Baclofen
- Sodium Oxybate
- Mixed Oxybate Salts
- Other
- Oral Solid Dosage Forms
- Immediate-release Oral Liquids
- Other
- Branded Drugs
- Generic Drugs
- Hospitals
- Clinics
- Other
- Jazz Pharmaceuticals
- Alkermes
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Piramal Pharma
- Azurity Pharmaceuticals
- Sagent Pharmaceuticals
- Novartis
- Daiichi Sankyo
- Fuan Pharmaceutical Group
1. How big is the global ?-Aminobutyric Acid Receptor Agonists market?
2. What is the demand of the global ?-Aminobutyric Acid Receptor Agonists market?
3. What is the year over year growth of the global ?-Aminobutyric Acid Receptor Agonists market?
4. What is the total value of the global ?-Aminobutyric Acid Receptor Agonists market?
5. Who are the Major Players in the global ?-Aminobutyric Acid Receptor Agonists market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 ?-Aminobutyric Acid Receptor Agonists Introduction
1.2 World ?-Aminobutyric Acid Receptor Agonists Market Size & Forecast (2021 & 2025 & 2032)
1.3 World ?-Aminobutyric Acid Receptor Agonists Total Market by Region (by Headquarter Location)
1.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.3 China Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.4 Europe Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.5 Japan Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.6 South Korea Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.7 ASEAN Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.8 India Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 ?-Aminobutyric Acid Receptor Agonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.2 World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region
2.2.1 World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region (2021-2026)
2.2.2 World ?-Aminobutyric Acid Receptor Agonists Consumption Value Forecast by Region (2027-2032)
2.3 United States ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.4 China ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.5 Europe ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.6 Japan ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.7 South Korea ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.8 ASEAN ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.9 India ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
3 WORLD ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS COMPANIES COMPETITIVE ANALYSIS
3.1 World ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global ?-Aminobutyric Acid Receptor Agonists Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for ?-Aminobutyric Acid Receptor Agonists in 2025
3.2.3 Global Concentration Ratios (CR8) for ?-Aminobutyric Acid Receptor Agonists in 2025
3.3 ?-Aminobutyric Acid Receptor Agonists Company Evaluation Quadrant
3.4 ?-Aminobutyric Acid Receptor Agonists Market: Overall Company Footprint Analysis
3.4.1 ?-Aminobutyric Acid Receptor Agonists Market: Region Footprint
3.4.2 ?-Aminobutyric Acid Receptor Agonists Market: Company Product Type Footprint
3.4.3 ?-Aminobutyric Acid Receptor Agonists Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison
4.2.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based ?-Aminobutyric Acid Receptor Agonists Companies and Market Share, 2021-2026
4.3.1 United States Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (States, Country)
4.3.2 United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026)
4.4 China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue and Market Share, 2021-2026
4.4.1 China Based ?-Aminobutyric Acid Receptor Agonists Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026)
4.5 Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies and Market Share, 2021-2026
4.5.1 Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Baclofen
5.2.2 Sodium Oxybate
5.2.3 Mixed Oxybate Salts
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
5.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2027-2032)
5.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Oral Solid Dosage Forms
6.2.2 Immediate-release Oral Liquids
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2021-2026)
6.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2027-2032)
6.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Branded Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2021-2026)
7.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2027-2032)
7.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
8.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2027-2032)
8.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Jazz Pharmaceuticals
9.1.1 Jazz Pharmaceuticals Details
9.1.2 Jazz Pharmaceuticals Major Business
9.1.3 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.1.4 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Jazz Pharmaceuticals Recent Developments/Updates
9.1.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Alkermes
9.2.1 Alkermes Details
9.2.2 Alkermes Major Business
9.2.3 Alkermes ?-Aminobutyric Acid Receptor Agonists Product and Services
9.2.4 Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Alkermes Recent Developments/Updates
9.2.6 Alkermes Competitive Strengths & Weaknesses
9.3 Hikma Pharmaceuticals
9.3.1 Hikma Pharmaceuticals Details
9.3.2 Hikma Pharmaceuticals Major Business
9.3.3 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.3.4 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Hikma Pharmaceuticals Recent Developments/Updates
9.3.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.4 Amneal Pharmaceuticals
9.4.1 Amneal Pharmaceuticals Details
9.4.2 Amneal Pharmaceuticals Major Business
9.4.3 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.4.4 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Amneal Pharmaceuticals Recent Developments/Updates
9.4.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.5 Piramal Pharma
9.5.1 Piramal Pharma Details
9.5.2 Piramal Pharma Major Business
9.5.3 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product and Services
9.5.4 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Piramal Pharma Recent Developments/Updates
9.5.6 Piramal Pharma Competitive Strengths & Weaknesses
9.6 Azurity Pharmaceuticals
9.6.1 Azurity Pharmaceuticals Details
9.6.2 Azurity Pharmaceuticals Major Business
9.6.3 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.6.4 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Azurity Pharmaceuticals Recent Developments/Updates
9.6.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Sagent Pharmaceuticals
9.7.1 Sagent Pharmaceuticals Details
9.7.2 Sagent Pharmaceuticals Major Business
9.7.3 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.7.4 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sagent Pharmaceuticals Recent Developments/Updates
9.7.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Novartis
9.8.1 Novartis Details
9.8.2 Novartis Major Business
9.8.3 Novartis ?-Aminobutyric Acid Receptor Agonists Product and Services
9.8.4 Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Novartis Recent Developments/Updates
9.8.6 Novartis Competitive Strengths & Weaknesses
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Details
9.9.2 Daiichi Sankyo Major Business
9.9.3 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product and Services
9.9.4 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Daiichi Sankyo Recent Developments/Updates
9.9.6 Daiichi Sankyo Competitive Strengths & Weaknesses
9.10 Fuan Pharmaceutical Group
9.10.1 Fuan Pharmaceutical Group Details
9.10.2 Fuan Pharmaceutical Group Major Business
9.10.3 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product and Services
9.10.4 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Fuan Pharmaceutical Group Recent Developments/Updates
9.10.6 Fuan Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 ?-Aminobutyric Acid Receptor Agonists Industry Chain
10.2 ?-Aminobutyric Acid Receptor Agonists Upstream Analysis
10.3 ?-Aminobutyric Acid Receptor Agonists Midstream Analysis
10.4 ?-Aminobutyric Acid Receptor Agonists Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 ?-Aminobutyric Acid Receptor Agonists Introduction
1.2 World ?-Aminobutyric Acid Receptor Agonists Market Size & Forecast (2021 & 2025 & 2032)
1.3 World ?-Aminobutyric Acid Receptor Agonists Total Market by Region (by Headquarter Location)
1.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.3 China Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.4 Europe Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.5 Japan Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.6 South Korea Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.7 ASEAN Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.3.8 India Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 ?-Aminobutyric Acid Receptor Agonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.2 World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region
2.2.1 World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region (2021-2026)
2.2.2 World ?-Aminobutyric Acid Receptor Agonists Consumption Value Forecast by Region (2027-2032)
2.3 United States ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.4 China ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.5 Europe ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.6 Japan ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.7 South Korea ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.8 ASEAN ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
2.9 India ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032)
3 WORLD ?-AMINOBUTYRIC ACID RECEPTOR AGONISTS COMPANIES COMPETITIVE ANALYSIS
3.1 World ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global ?-Aminobutyric Acid Receptor Agonists Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for ?-Aminobutyric Acid Receptor Agonists in 2025
3.2.3 Global Concentration Ratios (CR8) for ?-Aminobutyric Acid Receptor Agonists in 2025
3.3 ?-Aminobutyric Acid Receptor Agonists Company Evaluation Quadrant
3.4 ?-Aminobutyric Acid Receptor Agonists Market: Overall Company Footprint Analysis
3.4.1 ?-Aminobutyric Acid Receptor Agonists Market: Region Footprint
3.4.2 ?-Aminobutyric Acid Receptor Agonists Market: Company Product Type Footprint
3.4.3 ?-Aminobutyric Acid Receptor Agonists Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison
4.2.1 United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based ?-Aminobutyric Acid Receptor Agonists Companies and Market Share, 2021-2026
4.3.1 United States Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (States, Country)
4.3.2 United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026)
4.4 China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue and Market Share, 2021-2026
4.4.1 China Based ?-Aminobutyric Acid Receptor Agonists Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026)
4.5 Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies and Market Share, 2021-2026
4.5.1 Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Baclofen
5.2.2 Sodium Oxybate
5.2.3 Mixed Oxybate Salts
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2021-2026)
5.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2027-2032)
5.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Oral Solid Dosage Forms
6.2.2 Immediate-release Oral Liquids
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2021-2026)
6.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2027-2032)
6.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Branded Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2021-2026)
7.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2027-2032)
7.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World ?-Aminobutyric Acid Receptor Agonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026)
8.3.2 World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2027-2032)
8.3.3 World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Jazz Pharmaceuticals
9.1.1 Jazz Pharmaceuticals Details
9.1.2 Jazz Pharmaceuticals Major Business
9.1.3 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.1.4 Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Jazz Pharmaceuticals Recent Developments/Updates
9.1.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Alkermes
9.2.1 Alkermes Details
9.2.2 Alkermes Major Business
9.2.3 Alkermes ?-Aminobutyric Acid Receptor Agonists Product and Services
9.2.4 Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Alkermes Recent Developments/Updates
9.2.6 Alkermes Competitive Strengths & Weaknesses
9.3 Hikma Pharmaceuticals
9.3.1 Hikma Pharmaceuticals Details
9.3.2 Hikma Pharmaceuticals Major Business
9.3.3 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.3.4 Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Hikma Pharmaceuticals Recent Developments/Updates
9.3.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.4 Amneal Pharmaceuticals
9.4.1 Amneal Pharmaceuticals Details
9.4.2 Amneal Pharmaceuticals Major Business
9.4.3 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.4.4 Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Amneal Pharmaceuticals Recent Developments/Updates
9.4.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.5 Piramal Pharma
9.5.1 Piramal Pharma Details
9.5.2 Piramal Pharma Major Business
9.5.3 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product and Services
9.5.4 Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Piramal Pharma Recent Developments/Updates
9.5.6 Piramal Pharma Competitive Strengths & Weaknesses
9.6 Azurity Pharmaceuticals
9.6.1 Azurity Pharmaceuticals Details
9.6.2 Azurity Pharmaceuticals Major Business
9.6.3 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.6.4 Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Azurity Pharmaceuticals Recent Developments/Updates
9.6.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Sagent Pharmaceuticals
9.7.1 Sagent Pharmaceuticals Details
9.7.2 Sagent Pharmaceuticals Major Business
9.7.3 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
9.7.4 Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sagent Pharmaceuticals Recent Developments/Updates
9.7.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Novartis
9.8.1 Novartis Details
9.8.2 Novartis Major Business
9.8.3 Novartis ?-Aminobutyric Acid Receptor Agonists Product and Services
9.8.4 Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Novartis Recent Developments/Updates
9.8.6 Novartis Competitive Strengths & Weaknesses
9.9 Daiichi Sankyo
9.9.1 Daiichi Sankyo Details
9.9.2 Daiichi Sankyo Major Business
9.9.3 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product and Services
9.9.4 Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Daiichi Sankyo Recent Developments/Updates
9.9.6 Daiichi Sankyo Competitive Strengths & Weaknesses
9.10 Fuan Pharmaceutical Group
9.10.1 Fuan Pharmaceutical Group Details
9.10.2 Fuan Pharmaceutical Group Major Business
9.10.3 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product and Services
9.10.4 Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Fuan Pharmaceutical Group Recent Developments/Updates
9.10.6 Fuan Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 ?-Aminobutyric Acid Receptor Agonists Industry Chain
10.2 ?-Aminobutyric Acid Receptor Agonists Upstream Analysis
10.3 ?-Aminobutyric Acid Receptor Agonists Midstream Analysis
10.4 ?-Aminobutyric Acid Receptor Agonists Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key ?-Aminobutyric Acid Receptor Agonists Players in 2025
Table 12. World ?-Aminobutyric Acid Receptor Agonists Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global ?-Aminobutyric Acid Receptor Agonists Company Evaluation Quadrant
Table 14. Head Office of Key ?-Aminobutyric Acid Receptor Agonists Players
Table 15. ?-Aminobutyric Acid Receptor Agonists Market: Company Product Type Footprint
Table 16. ?-Aminobutyric Acid Receptor Agonists Market: Company Product Application Footprint
Table 17. ?-Aminobutyric Acid Receptor Agonists Mergers & Acquisitions Activity
Table 18. United States VS China ?-Aminobutyric Acid Receptor Agonists Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (States, Country)
Table 21. United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 23. China Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
Table 24. China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 26. Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 29. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2027-2032) & (USD Million)
Table 32. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & (USD Million)
Table 40. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2027-2032) & (USD Million)
Table 41. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Jazz Pharmaceuticals Major Business
Table 43. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 44. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Jazz Pharmaceuticals Recent Developments/Updates
Table 46. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Alkermes Basic Information, Manufacturing Base and Competitors
Table 48. Alkermes Major Business
Table 49. Alkermes ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 50. Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Alkermes Recent Developments/Updates
Table 52. Alkermes Competitive Strengths & Weaknesses
Table 53. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Pharmaceuticals Major Business
Table 55. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 56. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Hikma Pharmaceuticals Recent Developments/Updates
Table 58. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Amneal Pharmaceuticals Major Business
Table 61. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 62. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Amneal Pharmaceuticals Recent Developments/Updates
Table 64. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 66. Piramal Pharma Major Business
Table 67. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 68. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Piramal Pharma Recent Developments/Updates
Table 70. Piramal Pharma Competitive Strengths & Weaknesses
Table 71. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Azurity Pharmaceuticals Major Business
Table 73. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 74. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Azurity Pharmaceuticals Recent Developments/Updates
Table 76. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 78. Sagent Pharmaceuticals Major Business
Table 79. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 80. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sagent Pharmaceuticals Recent Developments/Updates
Table 82. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Manufacturing Base and Competitors
Table 84. Novartis Major Business
Table 85. Novartis ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 86. Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 90. Daiichi Sankyo Major Business
Table 91. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 92. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Daiichi Sankyo Recent Developments/Updates
Table 94. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 95. Fuan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 96. Fuan Pharmaceutical Group Major Business
Table 97. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 98. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Fuan Pharmaceutical Group Recent Developments/Updates
Table 100. Fuan Pharmaceutical Group Competitive Strengths & Weaknesses
Table 101. Global Key Players of ?-Aminobutyric Acid Receptor Agonists Upstream (Raw Materials)
Table 102. Global ?-Aminobutyric Acid Receptor Agonists Typical Customers
Table 1. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World ?-Aminobutyric Acid Receptor Agonists Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World ?-Aminobutyric Acid Receptor Agonists Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key ?-Aminobutyric Acid Receptor Agonists Players in 2025
Table 12. World ?-Aminobutyric Acid Receptor Agonists Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global ?-Aminobutyric Acid Receptor Agonists Company Evaluation Quadrant
Table 14. Head Office of Key ?-Aminobutyric Acid Receptor Agonists Players
Table 15. ?-Aminobutyric Acid Receptor Agonists Market: Company Product Type Footprint
Table 16. ?-Aminobutyric Acid Receptor Agonists Market: Company Product Application Footprint
Table 17. ?-Aminobutyric Acid Receptor Agonists Mergers & Acquisitions Activity
Table 18. United States VS China ?-Aminobutyric Acid Receptor Agonists Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China ?-Aminobutyric Acid Receptor Agonists Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (States, Country)
Table 21. United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 23. China Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
Table 24. China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 26. Rest of World Based ?-Aminobutyric Acid Receptor Agonists Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies ?-Aminobutyric Acid Receptor Agonists Revenue Market Share (2021-2026)
Table 29. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type (2027-2032) & (USD Million)
Table 32. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World ?-Aminobutyric Acid Receptor Agonists Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2021-2026) & (USD Million)
Table 40. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application (2027-2032) & (USD Million)
Table 41. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Jazz Pharmaceuticals Major Business
Table 43. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 44. Jazz Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Jazz Pharmaceuticals Recent Developments/Updates
Table 46. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Alkermes Basic Information, Manufacturing Base and Competitors
Table 48. Alkermes Major Business
Table 49. Alkermes ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 50. Alkermes ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Alkermes Recent Developments/Updates
Table 52. Alkermes Competitive Strengths & Weaknesses
Table 53. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Pharmaceuticals Major Business
Table 55. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 56. Hikma Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Hikma Pharmaceuticals Recent Developments/Updates
Table 58. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Amneal Pharmaceuticals Major Business
Table 61. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 62. Amneal Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Amneal Pharmaceuticals Recent Developments/Updates
Table 64. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Piramal Pharma Basic Information, Manufacturing Base and Competitors
Table 66. Piramal Pharma Major Business
Table 67. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 68. Piramal Pharma ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Piramal Pharma Recent Developments/Updates
Table 70. Piramal Pharma Competitive Strengths & Weaknesses
Table 71. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Azurity Pharmaceuticals Major Business
Table 73. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 74. Azurity Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Azurity Pharmaceuticals Recent Developments/Updates
Table 76. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 78. Sagent Pharmaceuticals Major Business
Table 79. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 80. Sagent Pharmaceuticals ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sagent Pharmaceuticals Recent Developments/Updates
Table 82. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. Novartis Basic Information, Manufacturing Base and Competitors
Table 84. Novartis Major Business
Table 85. Novartis ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 86. Novartis ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Novartis Recent Developments/Updates
Table 88. Novartis Competitive Strengths & Weaknesses
Table 89. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 90. Daiichi Sankyo Major Business
Table 91. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 92. Daiichi Sankyo ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Daiichi Sankyo Recent Developments/Updates
Table 94. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 95. Fuan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 96. Fuan Pharmaceutical Group Major Business
Table 97. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Product and Services
Table 98. Fuan Pharmaceutical Group ?-Aminobutyric Acid Receptor Agonists Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Fuan Pharmaceutical Group Recent Developments/Updates
Table 100. Fuan Pharmaceutical Group Competitive Strengths & Weaknesses
Table 101. Global Key Players of ?-Aminobutyric Acid Receptor Agonists Upstream (Raw Materials)
Table 102. Global ?-Aminobutyric Acid Receptor Agonists Typical Customers
LIST OF FIGURES
Figure 1. ?-Aminobutyric Acid Receptor Agonists Picture
Figure 2. World ?-Aminobutyric Acid Receptor Agonists Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World ?-Aminobutyric Acid Receptor Agonists Total Revenue (2021-2032) & (USD Million)
Figure 4. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 13. ?-Aminobutyric Acid Receptor Agonists Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 16. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share by Region (2021-2032)
Figure 17. United States ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 18. China ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 23. India ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of ?-Aminobutyric Acid Receptor Agonists by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for ?-Aminobutyric Acid Receptor Agonists Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for ?-Aminobutyric Acid Receptor Agonists Markets in 2025
Figure 27. United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type in 2025
Figure 31. Baclofen
Figure 32. Sodium Oxybate
Figure 33. Mixed Oxybate Salts
Figure 34. Other
Figure 35. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2032)
Figure 36. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form in 2025
Figure 38. Oral Solid Dosage Forms
Figure 39. Immediate-release Oral Liquids
Figure 40. Other
Figure 41. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 44. Branded Drugs
Figure 45. Generic Drugs
Figure 46. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2032)
Figure 47. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Clinics
Figure 51. Other
Figure 52. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2032)
Figure 53. ?-Aminobutyric Acid Receptor Agonists Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. ?-Aminobutyric Acid Receptor Agonists Picture
Figure 2. World ?-Aminobutyric Acid Receptor Agonists Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World ?-Aminobutyric Acid Receptor Agonists Total Revenue (2021-2032) & (USD Million)
Figure 4. World ?-Aminobutyric Acid Receptor Agonists Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World ?-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company ?-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (USD Million)
Figure 13. ?-Aminobutyric Acid Receptor Agonists Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 16. World ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share by Region (2021-2032)
Figure 17. United States ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 18. China ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 23. India ?-Aminobutyric Acid Receptor Agonists Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of ?-Aminobutyric Acid Receptor Agonists by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for ?-Aminobutyric Acid Receptor Agonists Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for ?-Aminobutyric Acid Receptor Agonists Markets in 2025
Figure 27. United States VS China: ?-Aminobutyric Acid Receptor Agonists Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: ?-Aminobutyric Acid Receptor Agonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World ?-Aminobutyric Acid Receptor Agonists Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type in 2025
Figure 31. Baclofen
Figure 32. Sodium Oxybate
Figure 33. Mixed Oxybate Salts
Figure 34. Other
Figure 35. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Type (2021-2032)
Figure 36. World ?-Aminobutyric Acid Receptor Agonists Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form in 2025
Figure 38. Oral Solid Dosage Forms
Figure 39. Immediate-release Oral Liquids
Figure 40. Other
Figure 41. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World ?-Aminobutyric Acid Receptor Agonists Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status in 2025
Figure 44. Branded Drugs
Figure 45. Generic Drugs
Figure 46. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Product Status (2021-2032)
Figure 47. World ?-Aminobutyric Acid Receptor Agonists Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Clinics
Figure 51. Other
Figure 52. World ?-Aminobutyric Acid Receptor Agonists Market Size Market Share by Application (2021-2032)
Figure 53. ?-Aminobutyric Acid Receptor Agonists Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
